BCL-2 expression aids in the immunohistochemical prediction of the Oncotype DX breast cancer recurrence score

BACKGROUND: The development of molecular techniques to estimate the risk of breast cancer recurrence has been a significant addition to the suite of tools available to pathologists and breast oncologists. It has previously been shown that immunohistochemistry can provide a surrogate measure of tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarella, Mark D., Heintzelman, Rebecca C., Popnikolov, Nikolay K., Garcia, Fernando U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299556/
https://www.ncbi.nlm.nih.gov/pubmed/30574014
http://dx.doi.org/10.1186/s12907-018-0082-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299556/
https://www.ncbi.nlm.nih.gov/pubmed/30574014
http://dx.doi.org/10.1186/s12907-018-0082-3

Ejemplares similares